AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,417,000 | +92.3% | 159,703 | -4.7% | 0.40% | +108.9% |
| Q2 2022 | $1,257,000 | -19.9% | 167,503 | -2.9% | 0.19% | -5.9% |
| Q1 2022 | $1,570,000 | +41.4% | 172,503 | +9.1% | 0.20% | +70.6% |
| Q4 2021 | $1,110,000 | -52.5% | 158,169 | -22.9% | 0.12% | -54.2% |
| Q3 2021 | $2,337,000 | -17.7% | 205,070 | +15.6% | 0.26% | -17.5% |
| Q2 2021 | $2,841,000 | +24.6% | 177,459 | +39.1% | 0.32% | +17.5% |
| Q1 2021 | $2,280,000 | +69.6% | 127,600 | +28.3% | 0.27% | +57.6% |
| Q4 2020 | $1,344,000 | +4700.0% | 99,440 | +4131.5% | 0.17% | +4150.0% |
| Q3 2020 | $28,000 | -24.3% | 2,350 | -7.8% | 0.00% | -33.3% |
| Q2 2020 | $37,000 | -9.8% | 2,550 | -16.4% | 0.01% | -25.0% |
| Q1 2020 | $41,000 | -25.5% | 3,050 | +32.6% | 0.01% | 0.0% |
| Q4 2019 | $55,000 | +10.0% | 2,300 | -11.5% | 0.01% | 0.0% |
| Q3 2019 | $50,000 | +78.6% | 2,600 | +173.7% | 0.01% | +100.0% |
| Q2 2019 | $28,000 | +16.7% | 950 | +90.0% | 0.00% | 0.0% |
| Q1 2019 | $24,000 | +33.3% | 500 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $18,000 | 0.0% | 500 | +66.7% | 0.00% | 0.0% |
| Q3 2018 | $18,000 | -10.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $20,000 | +25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $16,000 | +33.3% | 300 | +50.0% | 0.00% | +50.0% |
| Q4 2017 | $12,000 | +20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |